Contemporary Management of the Neurogenic Bladder for Multiple Sclerosis Patients

Stoffel, John T.

doi:10.1016/j.ucl.2010.06.003

Cited by 36 publications

(40 citation statements)

References 86 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Plaques in efferent or afferent pathways may impair emptying and urinary retention. 5 Although 63% of patients with sacral lesions show detrusor hypocontractility, only 5% present bladder areflexia. 6 …”

Section: Pathophysiology Of Lower Urinary Tract Symptoms (Luts) In Msmentioning

confidence: 99%

Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines

Aharony¹,

Lam²,

Corcos³

2017

CUAJ

View full text Add to dashboard Cite

Multiple sclerosis (MS) is a unique neurological disease with a broad spectrum of clinical presentations that are time-and disease course-related. MS plaque location (intracranial and/or spinal) is a key feature in the pathophysiology of disease-related lower urinary tract symptoms (LUTS). The prevalence of these symptoms in MS patients is very high, with nearly 90% of them experiencing some degree of voiding dysfunction and/or incontinence. LUTS rarely present as primary MS manifestations and usually appear 6-8 years after the initial diagnosis. Symptom severity usually correlates with the disability status of patients.Patient assessment comprises clinical and advanced investigations. Each patient should be evaluated uniquely, after taking into account his/her symptoms, disease course and length, comorbidities, physical status, and medications. Basic investigation includes detailed history-taking, physical examination, and post-void residual volume measurement. Advanced evaluation consists of imaging and specific testing, with pivotal importance on urodynamic study.

show abstract

Section: Pathophysiology Of Lower Urinary Tract Symptoms (Luts) In Msmentioning

confidence: 99%

Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines

Aharony¹,

Lam²,

Corcos³

2017

CUAJ

View full text Add to dashboard Cite

show abstract

“…1 MS patients frequently suffer from urinary complaints. [2][3][4] De Seze and colleagues 5 report a prevalence of 37-99% for overactive bladder syndromes, characterized by irritative bladder symptoms, a prevalence of 34-79% for obstructive symptoms and 25% for chronic urinary retention.…”

Section: Introductionmentioning

confidence: 99%

Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment

Akkoç

Ersöz²,

Yüceyar

et al. 2016

The Journal of Spinal Cord Medicine

View full text Add to dashboard Cite

Objective: To determine the frequency and severity as well as the diagnosis and treatment of overactive bladder problems in patients with multiple sclerosis (MS) followed up at five centers in Turkey. Design: Survey study. Setting: Outpatient tertiary clinics of physical medicine and rehabilitation and neurology. Participants: Consecutive MS patients scheduled for outpatient follow-up (n = 309). Intervention: MS patients were asked to complete a questionnaire regarding the frequency and severity, as well as the diagnosis and treatment of their overactive bladder problems. Results: The mean age ± SD was 39.3 ± 10.6 years. Urinary urgency was the most common urinary symptom (62%), followed by frequency (50.4%), urge incontinence (44.7%) and nocturia (33%). Residual urine volume was measured using a portable ultrasound instrument in 13.3% of the patients and by catheterization in 16.2% of them. Urodynamic investigations and urinary tract ultrasound were performed on 26.5% and 35.3% of the patients, respectively. Anticholinergic medications were prescribed for 27.5% of the patients. Intermittent catheterization and indwelling catheterization were used on 8.1% and 1.9% of the patients, respectively. The overactive bladder symptom score (OABSS) was significantly higher in patients who had had residual urine measurement (P < 0.001), upper urinary tract assessment by ultrasound (P < 0.001), urodynamic assessment (P < 0.001), admitted to a doctor for urinary symptoms (P < 0.001), and current or past catheter use (P = 0.002). Conclusion: Urgency was the most common urinary symptom followed by frequency, urge incontinence and nocturia in MS patients. The patients with lower OABSS had detailed urological assessments less frequently than the patients with higher OABSS.

show abstract

“…Garfinkle et al [3] described two cases of neurogenic bladder perforation in 1976. Detrusor areflexia is a very rare complication of multiple sclerosis, which requires permanent or intermittent catheterization [4]. Vaidyanathan et al discussed the dilema between cystotomy and intermittent catheterization in a patient with detrusor areflexia in neuromuscular disorders and type of catheters [5].…”

Section: Discussionmentioning

confidence: 99%

Acute abdomen due to bladder perforation in a patient with multiple sclerosis

Habek¹,

Pavelić-Turudić²,

Vukelić³

et al. 2013

Open Medicine

View full text Add to dashboard Cite

show abstract

Contemporary Management of the Neurogenic Bladder for Multiple Sclerosis Patients

Cited by 36 publications

References 86 publications

Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines

Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines

Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment

Acute abdomen due to bladder perforation in a patient with multiple sclerosis

Contact Info

Product

Resources

About